|
1
|
Govindan R, Page N, Morgensztern D, Read
W, Tierney R, Vlahiotis A, Spitznagel EL and Piccirillo J: Changing
epidemiology of small-cell lung cancer in the United States over
the last 30 years: analysis of the surveillance, epidemiologic, and
end results database. J Clin Oncol. 24:4539–4544. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Pignon JP, Arriagada R, Ihde DC, Johnson
DH, Perry MC, Souhami RL, Brodin O, Joss RA, Kies MS, Lebeau B, et
al: A meta-analysis of thoracic radiotherapy for small-cell lung
cancer. N Engl J Med. 327:1618–1624. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Warde P and Payne D: Does thoracic
irradiation improve survival and local control in limited-stage
small-cell carcinoma of the lung? A meta-analysis. J Clin Oncol.
10:890–895. 1992.PubMed/NCBI
|
|
4
|
Komaki R, Cox JD and Whitson W: Risk of
brain metastasis from small cell carcinoma of the lung related to
length of survival and prophylactic irradiation. Cancer Treat Rep.
65:811–814. 1981.PubMed/NCBI
|
|
5
|
Arriagada R, Le Chevalier T, Borie F,
Rivière A, Chomy P, Monnet I, Tardivon A, Viader F, Tarayre M and
Benhamou S: Prophylactic cranial irradiation for patients with
small-cell lung cancer in complete remission. J Natl Cancer Inst.
87:183–190. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Aupérin A, Arriagada R, Pignon JP, Le
Péchoux C, Gregor A, Stephens RJ, Kristjansen PE, Johnson BE, Ueoka
H, Wagner H and Aisner J: Prophylactic Cranial Irradiation Overview
Collaborative Group: Prophylactic cranial irradiation for patients
with small-cell lung cancer in complete remission. N Engl J Med.
341:476–484. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Sundstrøm S, Bremnes RM, Kaasa S, Aasebø
U, Hatlevoll R, Dahle R, Boye N, Wang M, Vigander T, Vilsvik J, et
al: Norwegian Lung Cancer Study Group: Cisplatin and etoposide
regimen is superior to cyclophosphamide, epirubicin, and
vincristine regimen in small-cell lung cancer: Results from a
randomized phase III trial with 5 years' follow-up. J Clin Oncol.
20:4665–4672. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Pujol JL, Carestia L and Daurès JP: Is
there a case for cisplatin in the treatment of small-cell lung
cancer? A meta-analysis of randomized trials of a
cisplatincontaining regimen versus a regimen without this
alkylating agent. Br J Cancer. 83:8–15. 2000.PubMed/NCBI
|
|
9
|
Perez CA, Krauss S, Bartolucci AA, Durant
JR, Lowenbraun S, Salter MM, Storaalsi J, Kellermeyer R and Comas
F: Thoracic and elective brain irradiation with concomitant or
delayed multiagent chemotherapy in the treatment of localized small
cell carcinoma of the lung: A randomized prospective study by the
Southeastern Cancer Study Group. Cancer. 47:2407–2413. 1981.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Sas-Korczyńska B, Korzeniowski S and
Wójcik E: Comparison of the effectiveness of “late” and “early”
prophylactic cranial irradiation in patients with limited-stage
small cell lung cancer. Strahlenther Onkol. 186:315–319. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Delaney G, Barton M, Jacob S and Jalaludin
B: A model for decision making for the use of radiotherapy in lung
cancer. Lancet Oncol. 4:120–128. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Giuliani M, Sun A, Bezjak A, Ma C, Le LW,
Brade A, Cho J, Leighl NB, Shepherd FA and Hope AJ: Utilization of
prophylactic cranial irradiation in patients with limited stage
small cell lung carcinoma. Cancer. 116:5694–5699. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Glantz MJ, Choy H and Yee L: Prophylactic
cranial irradiation in small cell lung cancer: Rationale, results,
and recommendations. Semin Oncol. 24:477–483. 1997.PubMed/NCBI
|
|
14
|
Wolfson AH, Bae K, Komaki R, Meyers C,
Movsas B, Le Pechoux C, Werner-Wasik M, Videtic GM, Garces YI and
Choy H: Primary analysis of a phase II randomized trial Radiation
Therapy Oncology Group (RTOG) 0212: Impact of different total doses
and schedules of prophylactic cranial irradiation on chronic
neurotoxicity and quality of life for patients with limited-disease
small-cell lung cancer. Int J Radiat Oncol Biol Phys. 81:77–84.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Arriagada R, Spielmann M, Koscielny S, Le
Chevalier T, Delozier T, Ducourtieux M, Tursz T and Hill C:
Patterns of failure in a randomized trial of adjuvant chemotherapy
in postmenopausal patients with early breast cancer treated with
tamoxifen. Ann Oncol. 13:1378–1386. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Patel S, Macdonald OK and Suntharalingam
M: Evaluation of the use of prophylactic cranial irradiation in
small cell lung cancer. Cancer. 115:842–850. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Takada M, Fukuoka M, Kawahara M, Sugiura
T, Yokoyama A, Yokota S, Nishiwaki Y, Watanabe K, Noda K, Tamura T,
et al: Phase III study of concurrent versus sequential thoracic
radiotherapy in combination with cisplatin and etoposide for
limited-stage small-cell lung cancer: Results of the Japan Clinical
Oncology Group Study 9104. J Clin Oncol. 20:3054–3060. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Gregor A, Drings P, Burghouts J, Postmus
PE, Morgan D, Sahmoud T, Kirkpatrick A, Dalesio O and Giaccone G:
Randomized trial of alternating versus sequential
radiotherapy/chemotherapy in limited-disease patients with
small-cell lung cancer: A European Organization for Research and
Treatment of Cancer Lung Cancer Cooperative Group Study. J Clin
Oncol. 15:2840–2849. 1997.PubMed/NCBI
|
|
19
|
Lebeau B, Urban T, Bréchot JM, Paillotin
D, Vincent J, Leclerc P, Meekel P, L'Her P, Lebas FX and Chastang
C: A randomized clinical trial comparing concurrent and alternating
thoracic irradiation for patients with limited small cell lung
carcinoma. “Petites Cellules” Group. Cancer. 86:1480–1487. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Chen AB, Neville BA, Sher DJ, Chen K and
Schrag D: Survival outcomes after radiation therapy for stage III
non-small-cell lung cancer after adoption of computed
tomography-based simulation. J Clin Oncol. 29:2305–2311. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Rosen ST, Makuch RW, Lichter AS, Ihde DC,
Matthews MJ, Minna JD, Glatstein E and Bunn PA Jr: Role of
prophylactic cranial irradiation in prevention of central nervous
system metastases in small cell lung cancer. Potential benefit
restricted to patients with complete response. Am J Med.
74:615–624. 1983. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
De Ruysscher D, Pijls-Johannesma M,
Vansteenkiste J, Kester A, Rutten I and Lambin P: Systematic review
and meta-analysis of randomised, controlled trials of the timing of
chest radiotherapy in patients with limited-stage, small-cell lung
cancer. Ann Oncol. 17:543–552. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ahles TA, Silberfarb PM, Herndon J II,
Maurer LH, Kornblith AB, Aisner J, Perry MC, Eaton WL, Zacharski
LL, Green MR and Holland JC: Psychologic and neuropsychologic
functioning of patients with limited small-cell lung cancer treated
with chemotherapy and radiation therapy with or without warfarin: A
study by the Cancer and Leukemia Group B. J Clin Oncol.
16:1954–1960. 1998.PubMed/NCBI
|
|
24
|
Fonseca R, O'Neill BP, Foote RL, Grill JP,
Sloan JA and Frytak S: Cerebral toxicity in patients treated for
small cell carcinoma of the lung. Mayo Clin Proc. 74:461–465. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ball DL and Matthews JP: Prophylactic
Cranial Irradiation: More Questions Than Answers. Semin Radiat
Oncol. 5:61–68. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ramlov A, Tietze A, Khalil AA and Knap MM:
Prophylactic cranial irradiation in patients with small cell lung
cancer. A retrospective study of recurrence, survival and
morbidity. Lung Cancer. 77:561–566. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Schild SE, Foster NR, Meyers JP, Ross HJ,
Stella PJ, Garces YI, Olivier KR, Molina JR, Past LR and Adjei AA:
North Central Cancer Treatment Group: Prophylactic cranial
irradiation in small-cell lung cancer: Findings from a North
Central Cancer Treatment Group Pooled Analysis. Ann Oncol.
23:2919–2924. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
van den Bent MJ: The role of chemotherapy
in brain metastases. Eur J Cancer. 39:2114–2120. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Goldstraw P, Crowley J, Chansky K, Giroux
DJ, Groome PA, Rami-Porta R, Postmus PE, Rusch V and Sobin L:
International Association for the Study of Lung Cancer
International Staging Committee; Participating Institutions: The
IASLC Lung Cancer Staging Project: proposals for the revision of
the TNM stage groupings in the forthcoming (seventh) edition of the
TNM Classification of malignant tumours. J Thorac Oncol. 2:706–714.
2007. View Article : Google Scholar : PubMed/NCBI
|
